Characteristics | OLTs from CRC | Early stage NSCLC | p |
---|---|---|---|
No. lesions | 24 | 48 | Â |
No. patients | 15 | 46 | Â |
Age (years) | Â | Â | 0.003 |
 Median | 62 | 78 |  |
 Range | 34–75 | 49–91 |  |
Gender | Â | Â | 0.063 |
 Male | 10 | 18 |  |
 Female | 5 | 28 |  |
Smoker | Â | Â | 0.019 |
 Smoker | 9 | 41 |  |
 Non-smoker | 6 | 5 |  |
Number of lesions per patient | Â | Â | 0.0008 |
 1 lesion | 9 | 44 |  |
 2 lesions | 3 | 2 |  |
 3 lesions | 3 | 0 |  |
Location | Â | Â | 1 |
 Central | 2 | 4 |  |
 Peripheral | 22 | 44 |  |
Tumor size (cm) |  |  | < 0.0001 |
 Median | 1 | 1.55 |  |
 Range | 0.4–1.8 | 0.5–2.8 |  |
Pathology |  |  | – |
 Adenocarcinoma | 24 | 48 |  |
Dose | Â | Â | < 0.00001 |
 50 Gy/5 fx | 1 | 0 |  |
 48 Gy/4 fx | 5 | 39 |  |
 60 Gy/5 fx | 18 | 9 |  |
Baseline SUVmax |  |  | < 0.0001 |
 Median | 3.2 | 5 |  |
 Range | 1.2–7.7 | 1.2–18.2 |  |
KRAS-mutation status | Â | Â | Â |
 Wild | 10 | – |  |
 Mutation | 11 | – |  |
 Unknown | 3 | – |  |